Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials M Monami, I Dicembrini, A Antenore, E Mannucci Diabetes care 34 (11), 2474-2476, 2011 | 352 | 2011 |
Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials M Monami, B Ahrén, I Dicembrini, E Mannucci Diabetes, Obesity and Metabolism 15 (2), 112-120, 2013 | 341 | 2013 |
Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials M Monami, I Dicembrini, D Martelli, E Mannucci Current Medical Research and Opinion 27 (sup3), 57-64, 2011 | 282 | 2011 |
Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials M Monami, I Dicembrini, E Mannucci Nutrition, Metabolism and Cardiovascular Diseases 24 (7), 689-697, 2014 | 242 | 2014 |
Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk: a meta‐analysis of randomized clinical trials M Monami, I Dicembrini, C Nardini, I Fiordelli, E Mannucci Diabetes, Obesity and Metabolism 16 (1), 38-47, 2014 | 214 | 2014 |
Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes. E Mannucci, F Tesi, G Bardini, A Ognibene, MG Petracca, S Ciani, ... Diabetes, nutrition & metabolism 17 (6), 336-342, 2004 | 190 | 2004 |
Is glucose control important for prevention of cardiovascular disease in diabetes? E Mannucci, I Dicembrini, A Lauria, P Pozzilli Diabetes care 36 (Suppl 2), S259, 2013 | 175 | 2013 |
Metformin and cancer occurrence in insulin-treated type 2 diabetic patients M Monami, C Colombi, D Balzi, I Dicembrini, S Giannini, C Melani, ... Diabetes care 34 (1), 129-131, 2011 | 153 | 2011 |
Effects of glucagon‐like peptide‐1 receptor agonists on body weight: a meta‐analysis M Monami, I Dicembrini, N Marchionni, CM Rotella, E Mannucci Journal of Diabetes Research 2012 (1), 672658, 2012 | 141 | 2012 |
Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials M Monami, I Dicembrini, E Mannucci Acta diabetologica 51, 91-101, 2014 | 134 | 2014 |
Dipeptidyl peptidase‐4 inhibitors and pancreatitis risk: a meta‐analysis of randomized clinical trials M Monami, I Dicembrini, E Mannucci Diabetes, Obesity and Metabolism 16 (1), 48-56, 2014 | 132 | 2014 |
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials M Monami, I Dicembrini, E Mannucci Acta diabetologica 54, 19-36, 2017 | 121 | 2017 |
Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials L Pala, I Dicembrini, E Mannucci Acta diabetologica 56, 973-980, 2019 | 114 | 2019 |
Comparison review of short-acting and long-acting glucagon-like peptide-1 receptor agonists A Uccellatore, S Genovese, I Dicembrini, E Mannucci, A Ceriello Diabetes therapy 6, 239-256, 2015 | 99 | 2015 |
Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels G Bardini, I Dicembrini, B Cresci, CM Rotella Diabetes care 33 (2), 411-413, 2010 | 96 | 2010 |
Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials M Monami, I Dicembrini, C Nardini, I Fiordelli, E Mannucci Diabetes research and clinical practice 103 (2), 269-275, 2014 | 94 | 2014 |
A meta‐analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes M Monami, I Dicembrini, L Kundisova, S Zannoni, B Nreu, E Mannucci Diabetes, Obesity and Metabolism 16 (9), 833-840, 2014 | 83 | 2014 |
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials I Dicembrini, B Nreu, A Scatena, F Andreozzi, G Sesti, E Mannucci, ... Acta diabetologica 54, 933-941, 2017 | 77 | 2017 |
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials I Dicembrini, C Cosentino, M Monami, E Mannucci, L Pala Acta diabetologica 58, 401-410, 2021 | 75 | 2021 |
Sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors and cancer: a meta‐analysis of randomized controlled trials I Dicembrini, B Nreu, E Mannucci, M Monami Diabetes, Obesity and Metabolism 21 (8), 1871-1877, 2019 | 64 | 2019 |